Glycyx PharmaVentures and Valeant Pharmaceuticals Agree to Binding Terms of Licensing Agreement in the Field of Oncology
Almost a year after Raymond James purchased Morgan Keegan , the integration has passed its last major milestone, which means the end of the venerable Morgan Keegan brand. The final integration will make Raymond James one of the largest brokerage firms behind the four wirehouses with almost 6,300 ...
Eight former directors overseeing mutual funds for Morgan Keegan & Co. settled, without paying any penalties, U.S. regulatory claims that they allowed assets backed by subprime mortgages to be overvalued as the housing market collapsed in 2007.
Morgan Keegan & Co. is going to trial before a judge whose decision to throw out regulators' claims the retail brokerage misled thousands of investors about the risks of auction-rate securities was reversed on appeal.
Eight former Morgan Keegan & Co. mutual-fund directors agreed to settle U.S. regulatory claims that they allowed assets backed by subprime mortgages to be overvalued as the housing market collapsed in 2007.
The Regions Morgan Keegan Funds were charged by the SEC with overstating the value of their securities as the housing market was collapsing in 2007.
Raymond James Financial plans to drop Morgan Keegan from the name of its fixed income arm later this month.
Raymond James said Tuesday it had wrapped up the conversion of Morgan Keegan operations and clients into Raymond James’ technology systems.
Plus, Harbor tees up a new fund, and more.
Also in the SEC's crosshairs recently: A penny-stock promoter nabbed in an undercover FBI sting and two medical insurance execs accused of a Ponzi scheme.